IQ-AI Limited (GB:IQAI) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
IQ-AI Limited’s subsidiary, Imaging Biometrics, has renewed its distribution agreement with GE HealthCare to expand the reach of its advanced imaging solutions. The agreement will see GE HealthCare selling IB Neuro and IB Delta T1 platforms, which are vital for brain tumor diagnosis and treatment monitoring. This collaboration aims to expedite the adoption of these innovative tools, enhancing healthcare providers’ capabilities and benefiting patients worldwide.
For further insights into GB:IQAI stock, check out TipRanks’ Stock Analysis page.